EyePoint PharmaceuticalsEYPT
那斯達克 · USD
10.48
-0.01
(-0.10%)
收盤 07/26 03:59 (UTC+8)
盤後
10.52
+0.04
(+0.38%)
07/26 03:59 (UTC+8)
EyePoint PharmaceuticalsEYPT
10.48
-0.01
(-0.10%)
財務數據
損益表
- 0.11
- 0.08
- 0.09
- 0.15
- 0.14
- 0.12
- 0.09
- 0.11
- 0.12
- 0.24
- 5.20
- -27.06
- 18.51
- 66.96
- -7.72
- -16.71
- -18.89
- 11.05
- 10.11
- 111.02
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 24,453 | 11,588 | 10,524 | 9,477 | 11,684 | 14,028 | 15,202 | 9,105 | 7,683 | 10,533 |
營業成本 | 805 | 816 | 736 | 1,401 | 759 | 998 | 1,202 | 1,792 | 640 | 3,410 |
營業毛利 | 23,648 | 10,772 | 9,788 | 8,076 | 10,925 | 13,030 | 14,000 | 7,313 | 7,043 | 7,123 |
營業費用 | - | - | 42,536 | 42,622 | 44,246 | 29,384 | 28,398 | 30,074 | 28,597 | 50,858 |
研發費用 | 58,574 | 43,372 | 29,543 | 29,872 | 30,139 | 17,951 | 17,363 | 15,730 | 13,618 | 15,543 |
推銷及管理費用 | 13,911 | 12,639 | 12,993 | 12,750 | 14,107 | 11,433 | 11,035 | 14,344 | 14,979 | 14,411 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | 20,699 |
其他營業費用 | - | - | - | - | - | - | - | - | - | 205 |
營業利益 | -48,837 | -45,239 | -32,748 | -34,546 | -33,321 | -16,354 | -14,398 | -22,761 | -21,554 | -43,735 |
其他收入及費用 | 3,642 | 3,944 | 3,387 | 3,720 | 4,037 | 2,338 | 1,786 | 276 | 1,202 | 1,064 |
利息費用 | - | 14 | - | - | - | - | - | 435 | 812 | 781 |
稅前純益 | -45,195 | -41,309 | -29,361 | -30,826 | -29,284 | -14,016 | -12,612 | -22,920 | -21,164 | -43,452 |
所得稅 | - | 90 | - | - | - | 83 | - | - | - | - |
稅後純益 | -45,195 | -41,399 | -29,361 | -30,826 | -29,284 | -14,099 | -12,612 | -22,920 | -21,164 | -43,452 |
基本每股稅後盈餘(元) | -0.65 | -0.64 | -0.54 | -0.58 | -0.55 | - | -0.33 | -0.61 | -0.56 | -1.16 |
稀釋每股稅後盈餘(元) | -0.65 | -0.65 | -0.54 | -0.58 | -0.55 | -0.32 | -0.33 | -0.61 | -0.56 | -1.16 |
基本平均股數(千股) | 69767.00 | 64556.00 | 54449.00 | 53206.00 | 52913.00 | - | 38341.00 | 37576.00 | 37486.00 | 37352.00 |
稀釋平均股數(千股) | 69767.00 | 64556.00 | 54449.00 | 53206.00 | 52913.00 | - | 38341.00 | 37576.00 | 37486.00 | 37352.00 |
還原基本每股稅後盈餘(元) | -0.65 | -0.64 | -0.54 | -0.58 | -0.55 | - | -0.33 | -0.61 | -0.56 | -1.16 |
還原稀釋每股稅後盈餘(元) | -0.65 | -0.65 | -0.54 | -0.58 | -0.55 | -0.32 | -0.33 | -0.61 | -0.56 | -1.16 |
還原基本平均股數(千股) | 69,767 | 64,556 | 54,449 | 53,206 | 52,913 | - | 38,341 | 37,576 | 37,486 | 37,352 |
還原稀釋平均股數(千股) | 69,767 | 64,556 | 54,449 | 53,206 | 52,913 | - | 38,341 | 37,576 | 37,486 | 37,352 |
EBITDA(千元) | -46,431 | -42,638 | -30,829 | -32,156 | -29,556 | -14,426 | -12,536 | -22,404 | -20,491 | -42,676 |